n(4)-hexadecyl-1-arabinofuranosylcytosine has been researched along with n(4)-octadecyl-1-arabinofuranosylcytosine in 2 studies
| Studies (n(4)-hexadecyl-1-arabinofuranosylcytosine) | Trials (n(4)-hexadecyl-1-arabinofuranosylcytosine) | Recent Studies (post-2010) (n(4)-hexadecyl-1-arabinofuranosylcytosine) | Studies (n(4)-octadecyl-1-arabinofuranosylcytosine) | Trials (n(4)-octadecyl-1-arabinofuranosylcytosine) | Recent Studies (post-2010) (n(4)-octadecyl-1-arabinofuranosylcytosine) |
|---|---|---|---|---|---|
| 8 | 0 | 0 | 5 | 0 | 1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horber, DH; Odermatt, B; Schott, H; Schwendener, RA | 1 |
| Hänseler, E; Rentsch, KM; Schott, H; Schwendener, RA | 1 |
2 other study(ies) available for n(4)-hexadecyl-1-arabinofuranosylcytosine and n(4)-octadecyl-1-arabinofuranosylcytosine
| Article | Year |
|---|---|
Oral antitumour activity in murine L1210 leukaemia and pharmacological properties of liposome formulations of N4-alkyl derivatives of 1-beta-D-arabinofuranosylcytosine.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Cytarabine; Drug Carriers; Female; Hemolysis; Humans; Leukemia L1210; Liposomes; Mice; Mice, Inbred ICR; Neoplasm Transplantation; Tissue Distribution | 1996 |
Sensitive high-performance liquid chromatographic method for the determination of N4-hexadecyl- and N4-octadecyl-1-beta-D-arabinofuranosylcytosine in plasma and erythrocytes.
Topics: Animals; Antineoplastic Agents; Butanols; Chromatography, High Pressure Liquid; Cytarabine; Erythrocytes; Female; Humans; Mice; Mice, Inbred ICR; Reproducibility of Results; Sensitivity and Specificity; Sonication; Urea | 1995 |